Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02911922 · ClinicalTrials.gov registry record · NA
Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT02911922 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 1 participants.
The verdict
NCT02911922, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
Patients with low-risk or favorable intermediate-risk prostate cancer as defined by 1.2016 NCCN criteria will be eligible to participate on this study.
Interventions
- RADIATION Radiation therapy
- DEVICE Endorectal Balloon
- DEVICE Rectal Spacer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-04-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02911922
The ClinicalTrials.gov registry entry for NCT02911922 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Radiation therapy is the first listed.
NCT02911922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02911922 about?
NCT02911922 is a clinical study titled "Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer". Patients with low-risk or favorable intermediate-risk prostate cancer as defined by 1.2016 NCCN criteria will be eligible to participate on this study.
What is the current status of trial NCT02911922?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2016-09. Estimated completion is 2018-04-17.
What interventions are being tested in trial NCT02911922?
The interventions under investigation include: Radiation therapy (RADIATION), Endorectal Balloon (DEVICE), Rectal Spacer (DEVICE).
Who is sponsoring clinical trial NCT02911922?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.